



























dEffects of Valve Replacement for Aortic Stenosis on
Mitral Regurgitation
Philippe Unger, MD, PhDa,*, Danièle Plein, MDd, Guy Van Camp, MD, PhDe,
Bernard Cosyns, MDf, Agnès Pasquet, MD, PhDg, Valérie Henrard, MDh,
Didier de Cannière, MD, PhDb, Christian Melot, MD, PhDc, Luc A. Piérard, MD, PhDh, and
Patrizio Lancellotti, MD, PhDh
We aimed to prospectively and quantitatively assess the effects of aortic valve replacement
(AVR) for aortic stenosis (AS) on mitral regurgitation (MR) and to examine the determi-
nants of the changes in MR. Fifty-two patients with AS scheduled for AVR were included
if holosystolic MR not being considered for replacement or repair was detected. MR was
quantified using the proximal isovelocity surface area method before and 8  4 days after
surgery. Mitral valvular deformation parameters did not change significantly, but the
mitral effective regurgitant orifice (ERO) and regurgitant volume decreased from 11  6
mm2 to 8 6 mm2 and from 20 10 ml to 11 9 ml, respectively (both p<0.0001). Using
multiple linear regression analysis, preoperative severity of MR, mitral leaflet coaptation
height, and end-diastolic volume decrease were independently associated with postopera-
tive reduction in MR, whereas changes in mitral valve morphology after surgery were not.
MR etiology did not predict the reduction in MR. In conclusion, the decrease in MR
observed in most patients after AVR is associated with the magnitude of acute left
ventricular reverse remodeling. As the reduction in left ventricular systolic pressure con-
tributes to the decrease in regurgitant volume, the preoperative quantitative assessment of
MR should best be performed by measurement of the ERO. © 2008 Elsevier Inc. All rights



























eitral regurgitation (MR) is a common finding in patients
ith aortic stenosis (AS). The severity of the MR increases
ver time in relation to the increase in transaortic pressure
radient.1 At the time of aortic valve replacement (AVR),
p to two-thirds of patients with AS exhibit varying degrees
f MR.2 Because combined aortic and mitral valve replace-
ent markedly increases the operative risk and affects long-
erm morbidity and mortality,3,4 it has been suggested that
R does not require specific treatment because downgrad-
ng of MR usually occurs after isolated AVR. In fact, AVR
or AS, by reducing left ventricular (LV) afterload, might
ave the potential to improve mitral valve competence
hrough reverse LV remodeling and reduced mitral annular
ize. Several authors2,5-13 have attempted to determine pre-
ictive factors for MR changes after surgery. However,
hese studies, mostly limited by their retrospective nature
nd/or by the qualitative or semi-quantitative assessment of
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oi:10.1016/j.amjcard.2008.07.021R, have given conflicting results. Indeed, the percentage
f patients with reduced MR ranges from 80%9 to
30%.8 No study has used a quantitative method for as-
essing MR in this setting. The extent and determinants of
hanges in MR after AVR, therefore, remain to be deter-
ined. Whether postoperative changes in MR reflect LV
emodynamics or LV and mitral valve geometric changes is
nknown. We therefore aimed to prospectively and quanti-
atively assess the effects of AVR on MR severity and to
xamine the determinants of postoperative changes in MR.
ethods
atients were included in this multicenter study if they
resented with severe AS and were scheduled for AVR and
ad at least mild holosystolic MR. Patients with MR being
onsidered for a concomitant mitral valve procedure were
xcluded, as were patients with previous mitral valve sur-
ery, technically inadequate echocardiogram, or greater
han moderate aortic regurgitation (vena contracta width6
m). Patients were also subsequently excluded from the
tudy if any surgical procedure on the mitral valve (repair or
eplacement) was performed. The final study group con-
isted of 52 patients. Coronary angiography was performed
n all patients. Significant coronary artery disease was con-
idered to be present if 50% narrowing of 1 coronary
rtery was present. Patients gave their informed consent,
nd the protocol was approved by the ethics committee of
ach institution.
Echocardiographic examinations were performed using


























































1379Valvular Heart Disease/Mitral Regurgitation and Aortic Valve Replacementnited Kingdom) or a Philips IE33 system (Philips Medical
ystem, Andover, Massachusetts). Data were recorded in
igital format and stored on optical or digital video disks for
ff-line analysis and were sent to a core echocardiographic
aboratory (Erasme Hospital). Quantitation of MR was per-
ormed by the proximal isovelocity surface area method as
reviously described.14 Briefly, the radius was measured
rom frames with optimal flow convergence. The largest
adius, usually in midsystole, was selected for analysis. The
itral valve effective regurgitant orifice (ERO) was calculated
s the ratio of regurgitant flow to peak regurgitant velocity, and
he regurgitant volume as the product of the ERO and the time
elocity integral of the regurgitant flow. For the postoperative
xamination, we assumed that regurgitant flow was zero when
olosystolic proximal isovelocity surface area or MR contin-
ous wave Doppler signal was absent. LV end-diastolic and
nd-systolic volumes and ejection fraction were measured by
he biapical modified Simpson disk method. The valvular tent-
ng area—the area enclosed between the annular plane and the
itral leaflets—was obtained from the parasternal long-axis
iew at midsystole.15 The distance between leaflet coaptation
nd the mitral annulus plane (coaptation height) was measured
n the apical 4-chamber view.
Left atrial area and regurgitant jet area were measured by
lanimetry from the apical 4-chamber view, allowing cal-
ulation of the ratio of regurgitant jet area to the left atrial
rea. Systolic pulmonary artery pressure was estimated
rom the systolic transtricuspid pressure gradient (in mm
g) using the modified Bernoulli equation (P  4 V2,
here Vmaximal tricuspid insufficiency velocity in m/s).
The etiology of MR was determined on the preoperative
chocardiogram and categorized as (1) functional, if occurring
able 1
emodynamic and geometric changes after aortic valve replacement
arameters P
aximal transaortic pressure gradient (mm Hg)
ean transaortic pressure gradient (mm Hg)
ortic valve area (cm2) 0
eart rate (beats per minute)
ystolic arterial pressure (mm Hg)
inus rhythm/Atrial fibrillation
eft ventricular end-diastolic diameter (cm) 5
eft ventricular end-systolic diameter (cm) 3
eft ventricular end-diastolic volume (ml/m2)
eft ventricular end-systolic volume (ml/m2)
eft ventricular ejection fraction (%)
eft ventricular mass (g)
eft atrial area (cm2)
atio of regurgitant jet area to left atrial area (%)
ime velocity integral of mitral regurgitant jet*
aximal velocity of mitral regurgitant jet*
itral regurgitant volume (ml) 1
itral effective regurgitant orifice (mm2) 1
itral tenting area (cm2) 2
itral coaptation height (cm) 0
* Analysis restricted to 46 patients because 6 patients had no postoperaithout valvular morphologic abnormality (except minor an- (
igure 1. Changes in quantified mitral regurgitation after aortic valve
eplacement. Effective regurgitant orifice (Panel A); regurgitant volumereoperative Postoperative p Value
n  52 n  52
71  25 25  10 0.0001
42  16 13  6 0.0001
.59  0.19 1.41  0.27 0.0001
80  17 82  16 0.34
124  19 124  21 0.85
42/10 40/12 0.81
.06  0.67 4.79  0.69 0.0001
.65  0.94 3.36  0.80 0.0004
94  37 80  32 0.0001
53  35 40  27 0.0001
49  16 54  14 0.0003
279  111 258  93 0.005
21  5 21  6 0.94
29  15 18  13 0.0001
181  34 137  3 0.0001
591  69 508  63 0.0001
9.6  10.0 11.3  8.9 0.0001
1.2  6.1 8.1  6.3 0.0001
.73  0.92 2.61  0.77 0.27






























































1380 The American Journal of Cardiology (www.AJConline.org)ular calcifications), with or without wall motion abnormalities
r LV dysfunction; or (2) organic, if associated with evidence
f leaflet, annular, chordal, or papillary muscle pathology.
atients were categorized by 2 independent observers (PU, PL)
nd in cases of discordance, by consensus.
Continuous variables were reported as means and SD
nd compared with a Student’s t test. One-way analysis of
ariance (for repeated measurements, when appropriate)
as used to compare more than 2 groups. If continuous
ariables were not normally distributed, comparisons were
ade using a Wilcoxon rank sum test and Kruskal-Wallis
onparametric tests. Categorical variables were reported as
ercentages and were compared using the Fisher’s exact
est. A value of p 0.05 was considered significant. Simple
nd multiple regression analysis using backward elimina-
ion were used to study the relationship between changes in
RO and in regurgitant volume (dependent variables) after
VR, and preoperative clinical and echocardiographic vari-
bles (independent variables). A value of p 0.10 was
onsidered significant to enter the variable into the multi-
ariate model. A similar analysis was performed to study
he determinants of AVR-induced changes in ERO and in
egurgitant volume by examining the relationship between
hanges in ERO and in regurgitant volume (dependent vari-
bles) and perioperative changes in echocardiographic vari-
bles (independent variables).
esults
he mean age was 77 years and the men/women ratio was
igure 2. Example of changes in mitral regurgitation induced by aortic valve
t baseline (Preop) and after aortic valve replacement (Postop), and typic
n calculated effective regurgitant orifice (ERO), whereas regurgitant volum
f regurgitant jet. R  proximal isovelocity surface area (PISA) radius; A2/30. Echocardiography was performed 6.3  10.8 days tmedian 1.5 days) before and 8.3  4.1 days (median 7
ays) after surgery. Functional MR was observed in 28
atients; 24 patients had organic (or mixed) MR, which
onsisted in moderate to severe calcific mitral valve disease
n all patients except 1 with mitral valve prolapse. Twenty-
ight patients had coronary artery disease, among whom 19
nderwent concomitant coronary bypass grafting (3 other
atients had had previous coronary artery revascularization
nd the remaining 6 had distal lesions, considered unsuit-
ble for revascularization). Forty-seven patients received a
ioprosthetic and 5 a mechanical aortic valve. Atrial fibril-
ation was observed preoperatively in 10 subjects and post-
peratively in 12.
The hemodynamic and geometric changes after AVR are
isted in Table 1. Mitral ERO and regurgitant volume both
ecreased (Figure 1). After surgery, there was a decrease in the
verage individual percentage decrease in ERO (25% 46%)
nd in regurgitant volume (40  41%), and in the ratio of the
egurgitant jet to left atrial area (37%  38%). The difference
n reduction was significant between ERO and regurgitant
olume (p0.0001) and between ERO and the ratio of regur-
itant jet to left atrial area (p 0.034). In addition, the degree
f change in MR was highly variable from patient to patient.
n example is presented in Figure 2. Thirty-six patients (69%)
xperienced a decrease in ERO (mean decrease 5.4  3.9
m2, range 0.5 to 18.2 mm2), 45 patients (87%) a decrease
n regurgitant volume (mean decrease 10.1  6.6 ml, range
.1 to 25.9 ml), and 43 (83%) a decrease in the regurgitant
et to left atrial area ratio (mean decrease 51%  25%). For
ement. Apical 4-chamber view showing proximal flow-convergence region
rn of regurgitant volume (Rvol) reduction. There is no significant change
edly decreases as a result of reduction in the time velocity integral (TVI)
aliasing velocity; Max V  maximal regurgitant flow velocity.replac
al patte























































































1381Valvular Heart Disease/Mitral Regurgitation and Aortic Valve Replacementncrease in ERO was 2.1 1.6 mm2 (range 0.1 to 4.8 mm2),
he increase in regurgitant volume was 3.4  2.9 ml (range
.1 to 8.1 ml), and the increase in the regurgitant jet to left
trial ratio was 27  19% (range 5% to 69%). Thirteen
atients (25%) had an ERO 15 mm2 preoperatively, com-
ared with 8 (15%) postoperatively (p  0.33); 23 patients
44%) had a regurgitant volume20 ml preoperatively, and
(17%) postoperatively (p  0.005).
MR etiology did not affect the magnitude of ERO changes
p 0.31), but the change in regurgitant volume was larger in
atients with organic MR (6.2  6.4 ml vs 10.6  8.6 ml for
unctional and organic MR, respectively; p  0.04).
hanges in MR were not predicted by the presence of
oronary artery disease (p  0.52 and 0.66 for ERO and
egurgitant volume, respectively), or the need for revascu-
arization by bypass grafting (p  0.76 and 0.74 for ERO
nd regurgitant volume, respectively). The preoperative pre-
ictors of decrease in MR are listed in Table 2. Using
able 2




itral effective regurgitant orifice reduction
Left ventricular mass 0.01 0.35
Left ventricular end-diastolic volume 0.02 0.32
Left ventricular end-systolic volume 0.02 0.31
Left ventricular ejection fraction 0.046 0.28
Mitral effective regurgitant orifice 0.009 0.36
Mitral regurgitant volume 0.049 0.27
Left atrial surface 0.03 0.30
Mitral coaptation height 0.008 0.37
Transtricuspid systolic pressure gradient 0.095 0.25
itral regurgitant volume reduction
Diastolic arterial blood pressure 0.07 0.26
Left ventricular mass 0.02 0.31
Left ventricular end-diastolic volume 0.09 0.23
Mitral effective regurgitant orifice 0.0005 0.46
Mitral regurgitant volume 0.0001 0.53
Left atrial area 0.002 0.43
Mitral coaptation height 0.03 0.30
Mitral tenting area 0.02 0.32
Only parameters with a value of p 0.10 are presented.
able 3
ostoperative echocardiographic parameters associated with mitral





eduction in effective regurgitant orifice
Reduction in left ventricular end-diastolic volume 0.0001 0.56
Reduction in left ventricular end-systolic volume 0.0001 0.52
eduction in regurgitant volume
Reduction in left ventricular end-diastolic volume 0.0009 0.45
Reduction in left ventricular end-systolic volume 0.02 0.32ultiple linear regression analysis, preoperative ERO (p  t.036) and mitral coaptation height (p  0.03) were inde-
endently associated with the decrease in ERO; only pre-
perative regurgitant volume (p  0.0001) remained asso-
iated with the decrease in regurgitant volume. In multiple
inear regression analysis, MR etiology was no longer an
ndependent predictor of the regurgitant volume reduction.
The decreases in ERO and in regurgitant volume were
ssociated with a reduction in LV volumes (Table 3) but not
ith an improvement in mitral tenting area (p  0.26 and
 0.21, respectively) or in coaptation height (p  0.29
nd p  0.18, respectively). By multivariable analysis, only
he reduction in LV end-diastolic volume was associated
ith a decrease in ERO and in regurgitant volume (p 
.001 for both variables).
iscussion
he main findings of this prospective study are (1) after
solated AVR for AS, most patients exhibit a significant
eduction in the quantified degree of MR; (2) the improve-
ent in regurgitant volume is more pronounced than the
eduction in ERO, the latter being a true marker of lesion
everity; (3) this postoperative improvement in MR is
ainly related to the severity of preoperative MR and the
xtent of mitral valvular deformation (coaptation height);
nd (4) the reduction in MR is associated with the magni-
ude of LV acute reverse remodeling, namely the decrease
n LV end-diastolic volume.
Several studies have described a reduction in the MR
olor jet area after AVR for AS, but there has been much
ebate regarding the magnitude of this decrease and the
umber of patients who improve.2,5-13 In addition, the tim-
ng of the postoperative echocardiographic examination var-
ed markedly among studies, ranging from the early post-
perative period 6,12 to 18 months after surgery.5 To the best
f our knowledge, the present study is the first to prospec-
ively assess the magnitude of changes in the quantified
egree of MR. After AVR, MR severity, as assessed by the
RO and the regurgitant volume, decreased in most pa-
ients, although it increased slightly in a minority of the
atients. The improvement was more pronounced in pa-
ients with the most severe MR, regardless of whether the
R was organic or functional. The mean reduction was
reater for the regurgitant volume (40%) and the color flow
apping of the regurgitant jet (37%) than for the mitral
RO (25%), emphasizing the importance of the reduction in
ystolic LV pressure. About 46% of our patients with a pre-
perative ERO10 mm2 improved and attained an ERO10
m2. Using a cut-off of 15 ml for regurgitant volume, MR
mproved of category in 60% of patients.
In aortic valve stenosis, MR may be functional, organic,
r both. In addition to the presence of concomitant structural
itral valve abnormalities, MR has been linked to various
eometric and hemodynamic changes. Preoperatively, the
ollowing parameters have been shown to be associated
ith a decrease in severity of MR: LV mass,11,12 LV func-
ion,9 left atrial diameter,5 and the degree of MR.7 In the
resent study, only the preoperative severity of MR and the
xtent of mitral valvular deformation as assessed by the coap-
ation height emerged as independent predictors of postopera-











































































1382 The American Journal of Cardiology (www.AJConline.org)Unlike several previous reports6,13 that described a larger
urgery-induced improvement in MR in patients with func-
ional MR, whether MR was functional or not in the present
tudy was not predictive of improvement in MR. This dis-
repancy may be related to the relatively small number of
atients with purely functional MR in the study by Barreiro
t al.,6 to the different time-delay of the postoperative echo-
ardiographic study (up to 1 year in the study by Vanden
ynden et al.13), and to the predominance of calcific mitral
alve disease in our elderly population. The coaptation
eight—a marker of increased tethering forces—is expected
o be higher in patients with functional MR. It could thus be
resumed that the larger the preoperative valvular deforma-
ion—reversible lesion—the greater would be the decrease
n MR after AVR. Reduction in MR was determined by the
cute reverse LV remodeling as assessed by the LV end-
iastolic volume. Changes in LV shape and geometry
ight, thus, also contribute to improved MR through a
ecrease in mitral tethering forces.16,17 However, neither the
hanges in mitral valve deformation parameters nor the
hanges in LV performance were predictive of MR im-
rovement. Such LV remodeling is probably the conse-
uence of correction of afterload mismatch. Whether pro-
ressive reverse LV remodeling could induce further MR
eduction over time needs to be addressed by long-term
erial echocardiographic studies. The decrease in regurgi-
ant volume outweighed the reduction in ERO. The regur-
itant volume is determined by the ERO, the systolic pres-
ure gradient across the orifice and the duration of
ystole.18,19 As LV cavity pressure drops early after surgery,
he transmitral pressure gradient decreases, resulting in MR
mprovement. Indeed, the reduction of the time-velocity
ntegral of the continuous-wave spectra of MR and of the
V to left atrial pressure difference contributed markedly to
he decrease in regurgitant volume. This observation differs
rom the changes reported after afterload reduction induced
y vasodilator therapy in heart failure patients with dynamic
R, in which the time-velocity integral and the systolic
lood pressure to left atrial pressure gradient remain unal-
ered.20 Taken together, these results suggest that systolic
V pressure reduction is a main contributor to the early
ostoperative reduction in regurgitant volume, whereas cor-
ection of mitral valve geometry plays little or no role.
The effects of changes in medical treatment after AVR
ere not taken into account. However, systolic blood pres-
ure did not change significantly. Moreover, the main change
as a reduction in regurgitant volume, making an effect of
asodilator therapy less likely; the pharmacological reduction
f LV filling pressure and systemic vascular resistance have
een shown to translate into a reduction in regurgitant volume
ainly through a decrease in ERO and not through a change in
he pressure gradient across the mitral valve.20 Because of the
esign of the study, no patient had severe MR. Indeed, the
resence of severe MR was an obvious indication to proceed to
ouble valve surgery. A high percentage of our study popula-
ion consisted of elderly patients, which is reflected by the
arge number of calcified mitral valve disease. Whether our
esults are applicable to younger patients remains uncertain;
ne may hypothesize that the frequent occurrence of annular
alcification in our population may be associated with a more
xed regurgitant orifice. The possible effects of prosthesis–atient mismatch were not examined. Finally, long-term serial
chocardiographic studies are required to assess the effects of
rogressive LV and mitral remodeling over time and the prog-
ostic importance of MR quantification in this clinical setting.
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